Serological detection of attenuated HIV-1 variants with nef gene deletions

AIDS

Volumn 12, Issue 6, 1998, Pages 555-561

  Greenway, Alison L ^a   Mills, John ^a   Rhodes, David ^a   Deacon, Nicholas J ^a   McPhee, Dale A ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

Antibody detection; Attenuated virus; HIV 1; Long term non progression; Nef; nef deletions; Screening assay

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEF PROTEIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SERODIAGNOSIS; VIRUS ATTENUATION; VIRUS GENE;

EID: 0032537170     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199806000-00003     Document Type: Article

References (24)

1. Greenough TC, Somasundaran M, Brettler DB, et al.: Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994, 10:395-403.
2. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Absence of intact nef sequences in a long-term survivor with non-progressive HIV-1 infection. N Engl J Med 1995, 332:228-232.
3. Can Y, Qin L, Zhang L, Safrit J, Ho D: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995, 332:201-208.
4. Deacon NJ, Tsykin A, Solomon A, et al.: Genomic structure of an attenuated quasispecies of HIV-1 from a cohort of a blood transfusion donor and recipients. Science 1995, 270:988-991.
5. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, Skowronski J: High frequency of defective nef allelles in a long term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 1996, 70:7752-7764.
6. Kestler HW, Ringler DJ, Mori K, et al.: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65:651-662.
7. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB: The human immunodeficiency-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994, 179:101-113.
8. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994, 179:115-123.
9. Learmont J, Tindall B, Evans L, et al.: Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992, 34:863-867.
10. Learmont J, Cook L, Dunckley H, Sullivan J: Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor [letter]. AIDS Res Hum Retroviruses 1995, 11:1.
11. Kirchhoff F, Kestler HW, Desrosiers RC: Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol 1994, 68:2031-2037.
12. Black FL, Rosen L: Patterns of measles antibodies in residents of Tahiti and their stability in the absence of reexposure. J Immunol 1962, 88:725-731.
13. Webster RG, Kasel JA, Couch RB, Laver WG: Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Infect Dis 1976, 134:48-58.
14. Fecondo JV, Pavuk NC, Silburn KA, et al.: Synthetic peptide analogs of intercellular adhesion molecule 1 (ICAM-1) inhibit HIV-1 replication in MT-2 cells. AIDS Res Hum Retroviruses 1993, 9:733-739.
15. Gombert FO, Blecha W, Tahtinen M, et al.: Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection. Virology 1990, 176:458-466.
16. Schneider T, Harthus H-P, Hilderbrandt P, et al.: Epitopes of the HIV-1 negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1 positive sera. AIDS Res Hum Retroviruses 1991, 7:37-44.
17. Azad A, Failla P, Lucantoni A, et al.: Large scale production and characterization of recombinant human immunodeficiency virus type-1 Nef. J Gen Virol 1994, 75:651-655.
18. Cumming SA, McPhee DA, Maskill WJ, Kemp BE, Doherty RR, Gust ID: Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies. AIDS 1990, 4:83-86.
19. Grzesiek S, Bax A, Clore GM, et al.: The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Struct Biol 1996, 3:340-345.
20. Reiss P, de Rhonde A, Lange JMA, et al.: Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression. AIDS 1989, 3:227-233.
21. Cheingsong-Popov R, Panagiotidi C, Ali M, et al.: Antibodies to HIV-1 nef (p27): prevalence, significance, and relationship to seroconversion. AIDS Res Hum Retroviruses 1990, 6:1099-1104.
22. Sabatier J-M, Clerget-Raslan B, Fonta G, et al.: Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients. AIDS 1989, 3:215-220.
23. Myers C, Korber B, Hahn BH, et al. (Eds): Human Retroviruses and AIDS 1995. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos: Los Alamos National Laboratory; 1995:II-A-109.
24. Shugars DC, Smith MS, Glueck DH, Nantermet PV, Seillier-Moiseiwitsch F, Swanstrom R: Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol 1993, 67:4639-4650.